| IQVIA HLDGS DL-,01 |
| USA |
| Gesundheit |
| US46266C1053 / A2JSPM |
| QTS (Frankfurt) / IQV (NYSE) |
| FRA:QTS, ETR:QTS, QTS:GR, NYSE:IQV |
| S&P500 |
| https://www.iqvia.com/ |
|
IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company operates three primary divisions: Research & Development, which manages all phases..
>Volltext.. |
| 24570.61 Mio. EUR |
| 36769.17 Mio. EUR |
| 14204.22 Mio. EUR |
| 2983.98 Mio. EUR |
| 1182.83 Mio. EUR |
| 6.95 EUR |
| 13719.98 Mio. EUR |
| 1662.8 Mio. EUR |
| - |
| 0.25 |
| 0.5% |
| -2.78% |
| - |
| - |
| - |
| - |
| IQVIA |
| 16.05.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|